Correlation between consumption of probiotic products and post-stroke depression in patients with ischemic stroke
10.3760/cma.j.issn.1673-4165.2022.07.002
- VernacularTitle:益生菌制品消费与缺血性卒中患者卒中后抑郁的相关性
- Author:
Zhi QI
1
;
Dan ZHU
;
Aili WANG
;
Shi WANG
;
Haiping YU
Author Information
1. 同济大学医学院，上海 200092
- Keywords:
Stroke;
Brain ischemia;
Depression;
Probiotics;
Gastrointestinal microbiome;
Risk factors
- From:
International Journal of Cerebrovascular Diseases
2022;30(7):489-493
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the correlation between the consumption level of probiotic products and post-stroke depression (PSD).Methods:Patients with ischemic stroke visited the Department of Neurology, the Third Affiliated Hospital of Naval Medical University from May 2021 to January 2022 were prospectively enrolled. According to self-rating depression scale (SDS), they were divided into PSD group (SDS score ≥53) and non-PSD group (SDS score <53). The influence factors of PSD were determined by comparing the demographic data, clinical data and consumption level of probiotic products between the two groups. Multivariate logistic regression analysis was used to determine the independent correlation between PSD and the consumption level of probiotic products. Results:A total of 120 patients with ischemic stroke were enrolled, including 39 (32.5%) in the PSD group and 81 (67.5%) in the non-PSD group. Multivariate logistic regression analysis showed that after adjusting for potential confounding factors, the severity of infarction (odds ratio 1.276, 95% confidence interval 1.138-1.432; P<0.001) and the consumption level of probiotic products (odds ratio 0.300, 95% confidence interval 0.098-0.916; P=0.035) were the independent influencing factors of PSD. Conclusion:The consumption level of probiotic products is an independent protective factor for PSD, and higher consumption level of probiotic products is associated with lower PSD incidence.
